SRTS
Sensus Healthcare, IncstockNASDAQ
sensus healthcare, inc. is a medical device company that is committed to enabling non-invasive and cost-effective treatment of non-melanoma skin cancer and keloids. sensus uses a proprietary low energy x-ray radiation technology known as superficial radiation therapy (srt), which is a result of over a decade of dedicated research and development activities. sensus has successfully incorporated the srt therapy into its portfolio of treatment devices: srt-100™ and srt-100 vision™. srt technology effectively and safely treats oncological and non-oncological skin conditions. for more information, visit http://www.sensushealthcare.com.
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 3.00 | 2026-09-28 | +0.17% | 1.100 |
| 1M | 3.19 | 2026-09-04 | -5.96% | 0.994 |
| 3M | 3.05 | 2026-07-06 | -1.64% | 0.711 |
| 6M | 4.23 | 2026-04-06 | -29.08% | 0.312 |
| 1Y | 3.43 | 2025-10-03 | -12.54% | 0.886 |
| 2Y | 6.29 | 2024-10-04 | -52.30% | — |
| 5Y | 3.70 | 2021-10-04 | -18.81% | 0.935 |
Sensus Healthcare, Inc (NASDAQ:SRTS) stock price today is $3.00, and today's volume is 17,173. SRTS is up 1.695% today. The 30 day average volume is 35,475. SRTS market cap is $49.39M with 16.46M shares outstanding.
